| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
51,320,000 |
| Market
Cap: |
4.56(B) |
| Last
Volume: |
478,561 |
Avg
Vol: |
495,679 |
| 52
Week Range: |
$71.24 - $97.37 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P SMALLCAP 600 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 438 |
| Guru Rank Value : 3.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Haemonetics is a global healthcare company providing a suite of medical products and solutions for customers. Co.'s technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Co. has three principal reporting segments: Plasma, which provides automated plasma collection and donor management software systems; Blood Center, which provides a range of solutions that improve donor collection centers' ability to collect and filter blood and separate blood components; and Hospital, which has four product lines, including Hemostasis Management, Vascular Closure, Transfusion Management and Cell Salvage.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
31,812 |
31,812 |
52,026 |
112,090 |
| Total Sell Value |
$2,869,033 |
$2,869,033 |
$4,659,768 |
$9,328,076 |
| Total People Sold |
4 |
4 |
5 |
9 |
| Total Sell Transactions |
11 |
11 |
16 |
30 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Pomeroy Claire |
Director |
• • – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,730 |
9,746 |
|
- |
|
| Kroll Mark W |
Director |
• • – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,730 |
24,247 |
|
- |
|
| Johnson Lloyd Emerson |
Director |
• • – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,730 |
5,807 |
|
- |
|
| Coyle Michael J |
Director |
• • – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,730 |
8,268 |
|
- |
|
| Zane Ellen M |
Director |
• • – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,730 |
12,247 |
|
- |
|
| Abernathy Robert E |
Director |
• • – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,730 |
17,855 |
|
- |
|
| Dockendorff Charles J |
Director |
• • – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,730 |
28,130 |
|
- |
|
| Miller Laurie A. |
SVP, Human Resources |
• • – |
2022-07-05 |
4 |
S |
$66.18 |
$2,780 |
D/D |
(42) |
12,909 |
|
-19% |
|
| Miller Laurie A. |
SVP, Human Resources |
• • – |
2022-06-13 |
4 |
S |
$62.60 |
$1,878 |
D/D |
(30) |
12,951 |
|
-26% |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2022-06-13 |
4 |
S |
$62.60 |
$17,340 |
D/D |
(277) |
40,635 |
|
-26% |
|
| Simon Christopher |
President & CEO |
• • – |
2022-06-13 |
4 |
S |
$62.60 |
$71,865 |
D/D |
(1,148) |
213,724 |
|
-26% |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2022-06-13 |
4 |
S |
$62.60 |
$2,629 |
D/D |
(42) |
4,447 |
|
-26% |
|
| Miller Laurie A. |
SVP, Human Resources |
• • – |
2022-06-02 |
4 |
S |
$62.69 |
$12,413 |
D/D |
(198) |
12,981 |
|
-17% |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2022-06-02 |
4 |
S |
$62.69 |
$15,610 |
D/D |
(249) |
4,489 |
|
-17% |
|
| Llorens Josep |
EVP, Global Manufacturing |
• • – |
2022-05-19 |
4 |
S |
$59.10 |
$83,804 |
D/D |
(1,418) |
17,335 |
|
-22% |
|
| Strong Stewart W |
President, Global Hospital |
• • – |
2022-05-19 |
4 |
S |
$59.10 |
$64,064 |
D/D |
(1,084) |
15,756 |
|
-22% |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2022-05-19 |
4 |
S |
$59.10 |
$192,548 |
D/D |
(3,258) |
40,912 |
|
-22% |
|
| Simon Christopher |
President & CEO |
• • – |
2022-05-19 |
4 |
S |
$59.10 |
$147,514 |
D/D |
(2,496) |
214,872 |
|
-22% |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2022-05-19 |
4 |
S |
$59.10 |
$7,919 |
D/D |
(134) |
4,738 |
|
-22% |
|
| Lingamneni Anila |
EVP, Chief Technology Officer |
• • – |
2022-05-19 |
4 |
S |
$59.10 |
$81,794 |
D/D |
(1,384) |
17,322 |
|
-22% |
|
| Miller Laurie A. |
SVP, Human Resources |
• • – |
2022-05-19 |
4 |
S |
$59.10 |
$5,378 |
D/D |
(91) |
13,179 |
|
-22% |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2022-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
868 |
4,872 |
|
- |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2022-05-16 |
4 |
S |
$56.10 |
$2,805 |
D/D |
(50) |
4,004 |
|
-25% |
|
| Lingamneni Anila |
EVP, Chief Technology Officer |
• • – |
2022-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
4,340 |
18,706 |
|
- |
|
| Llorens Josep |
EVP, Global Manufacturing |
• • – |
2022-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
4,340 |
18,753 |
|
- |
|
1368 Records found
|
|
Page 6 of 55 |
|
|
0.92 (1.05%) 
